Multikinase inhibitors

TEVA 8231 TEVA 8231 Pill - brown capsule-shape, 18mm

Pill with imprint TEVA 8231 TEVA 8231 is Brown, Capsule-shape and has been identified as Sunitinib Malate 50 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Sunitinib is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sunitinib (Sunitinib [ soo-nit-in-ib ])-TEVA 8231 TEVA 8231-50 mg-Brown-Capsule-shape

Sunitinib
Generic Name: sunitinib [ soo-nit-in-ib ]
Imprint: TEVA 8231 TEVA 8231
Strength: 50 mg
Color: Brown
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00093-8231
Inactive Ingredients: Croscarmellose sodium, Magnesium stearate, Mannitol, Povidone k30, FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, Gelatin, Titanium dioxide, Ferrosoferric oxide, FD&C Blue No. 1 Aluminium Lake, FD&C Blue No. 2 Aluminium Lake, Shellac, Propylene glycol,
Latest News
Related Drugs